Variant report
Variant | esv3397207 |
---|---|
Chromosome Location | chr10:1841352-1845650 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr10:1842245..1844057-chr10:1846999..1848882,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs576963887 | chr10:1841354-1841355 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs147916114 | chr10:1841358-1841359 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs11250793 | chr10:1841381-1841382 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs77689053 | chr10:1841393-1841394 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs140074892 | chr10:1841395-1841396 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs562240859 | chr10:1841414-1841415 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs527894089 | chr10:1841429-1841430 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs376435080 | chr10:1841430-1841431 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs547477440 | chr10:1841440-1841441 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs570554973 | chr10:1841445-1841446 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs539589900 | chr10:1841465-1841466 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs549730139 | chr10:1841479-1841480 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs12412246 | chr10:1841505-1841506 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs535707306 | chr10:1841521-1841522 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs570306312 | chr10:1841530-1841531 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs145368265 | chr10:1841549-1841550 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs555376372 | chr10:1841578-1841579 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs571869111 | chr10:1841625-1841626 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs534500291 | chr10:1841648-1841649 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs557577523 | chr10:1841668-1841669 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs576902889 | chr10:1841673-1841674 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs570917815 | chr10:1841675-1841676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs373841804 | chr10:1841718-1841719 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs546012934 | chr10:1841737-1841738 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs562864967 | chr10:1841739-1841740 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs563474270 | chr10:1841756-1841757 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs142110243 | chr10:1841769-1841770 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs374229308 | chr10:1841774-1841775 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs542463906 | chr10:1841776-1841777 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs562380120 | chr10:1841821-1841822 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs61833581 | chr10:1841825-1841826 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs372626940 | chr10:1841835-1841836 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs528034776 | chr10:1841852-1841853 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs79965146 | chr10:1841862-1841863 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs536045119 | chr10:1841931-1841932 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs190958221 | chr10:1841990-1841991 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs555930898 | chr10:1842003-1842004 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs145592210 | chr10:1842004-1842005 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs182074779 | chr10:1842018-1842019 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs549627076 | chr10:1842093-1842094 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs569586671 | chr10:1842120-1842121 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs116553585 | chr10:1842123-1842124 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs548608740 | chr10:1842124-1842125 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs116050521 | chr10:1842127-1842128 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs187883624 | chr10:1842162-1842163 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs557510858 | chr10:1842170-1842171 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs571123205 | chr10:1842230-1842231 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs34527784 | chr10:1842261-1842262 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs369081201 | chr10:1842277-1842278 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs4880922 | chr10:1842283-1842284 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 20409316 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Pilocytic astrocytoma | 18622384 | CNVD |
Pilomyxoid astrocytoma | 18622384 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Cancer | 21129771 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Digeorge syndrome | 22283845 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Wilms tumour | 19047088 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Barakat syndrome | 22470819 | CNVD |
Melanoma | 18172304 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Autism | 18414403 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Breast cancer | 22032731 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Melanoma | 17363583 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Oral cancer | 21386901 | CNVD |
Breast cancer | 21785460 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Breast cancer | 21509527 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Autism | 22543975 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:1808600-1853400 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr10:1843000-1843600 | Active TSS | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr10:1843200-1843400 | Bivalent Enhancer | Fetal Brain Male | brain |
4 | chr10:1843400-1843600 | Flanking Bivalent TSS/Enh | Fetal Brain Male | brain |
5 | chr10:1843600-1843800 | Bivalent Enhancer | Fetal Brain Male | brain |
6 | chr10:1843600-1851400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
7 | chr10:1843800-1844000 | Enhancers | Fetal Brain Male | brain |
8 | chr10:1844600-1845000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
9 | chr10:1844600-1845200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
10 | chr10:1844600-1845200 | Enhancers | Dnd41 | blood |
11 | chr10:1844600-1845200 | Enhancers | Hela-S3 | cervix |
12 | chr10:1844800-1845400 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |